Skip to content
  • Home
  • About Us
  • News

News

September 9, 2020

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

  1. Home
  2. News

Inherent Biosciences is a molecular diagnostics company at the intersection of epigenetics and AI. Our vision is to revolutionize trial and error medicine and restore hope.

  • Home
  • About Us
  • News
© 2020 Inherent Biosciences